Replies to post #222405 on Biotech Values

[DewDiligence]

Is there a rationale for induction chemo followed by Imbruvica/Rituxan (without chemo)?

[DewDiligence]

Imbruvica shows impressive duration of response in CLL/SLL:

https://www.prnewswire.com/news-releases/imbruvica-ibrutinib-data-in-chronic-lymphocytic-leukemia-cll-show-up-to-seven-years-of-progression-free-survival-pfs-in-80-percent-of-previously-untreated-patients-the-longest-follow-up-for-a-brutons-tyrosine-kinase-inhib-300758683.html